Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Journal of Medicinal Chemistry
|
March 2, 1992
Synthesis, cardiac electrophysiology, and beta-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents
G B Phillips, T K Morgan, W C Lumma, et al.
Journal of Medicinal Chemistry
|
June 1, 1978
Piperazinylpyrazines with central serotoninmimetic activity
W C Lumma, R D Hartman, W S Saari, et al.
Journal of Medicinal Chemistry
|
November 1, 1979
Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents
J J Baldwin, W C Lumma, G F Lundell, et al.
Journal of Medicinal Chemistry
|
April 1, 1987
Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds
R Lis, T K Morgan, R J DeVita, et al.
Journal of Medicinal Chemistry
|
March 14, 1997
Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site
T J Tucker, W C Lumma, A M Mulichak, et al.
Journal of Medicinal Chemistry
|
February 1, 1983
Conformational requirements for histamine H2-receptor inhibitors: a structure-activity study of phenylene analogues related to cimetidine and tiotidine
J M Hoffman, A M Pietruszkiewicz, C N Habecker, et al.
Journal of Medicinal Chemistry
|
August 1, 1987
Cardiotonic agents. 2. (Imidazolyl)aroylimidazolones, highly potent and selective positive inotropic agents
A A Hagedorn, P W Erhardt, W C Lumma, et al.
Journal of Medicinal Chemistry
|
April 17, 1998
Design of novel, potent, noncovalent inhibitors of thrombin with nonbasic P-1 substructures: rapid structure-activity studies by solid-phase synthesis
W C Lumma, K M Witherup, T J Tucker, et al.
Journal of Medicinal Chemistry
|
April 1, 1990
Synthesis and pharmacological studies of N-[4-[2-hydroxy-3-[[2-[4-(1H-imidazol-1- yl)phenoxy]ethyl]amino]propoxy]phenyl]methanesulfonamide, a novel antiarrhythmic agent with class II and class III activities
T K Morgan, R Lis, W C Lumma, et al.
Journal of Medicinal Chemistry
|
April 1, 1990
Synthesis and cardiac electrophysiological activity of N-substituted-4-(1H-imidazol-1-yl)benzamides--new selective class III agents
T K Morgan, R Lis, W C Lumma, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Journal of Medicinal Chemistry
|
March 2, 1992
Synthesis, cardiac electrophysiology, and beta-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents
G B Phillips, T K Morgan, W C Lumma, et al.
Journal of Medicinal Chemistry
|
June 1, 1978
Piperazinylpyrazines with central serotoninmimetic activity
W C Lumma, R D Hartman, W S Saari, et al.
Journal of Medicinal Chemistry
|
November 1, 1979
Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents
J J Baldwin, W C Lumma, G F Lundell, et al.
Journal of Medicinal Chemistry
|
April 1, 1987
Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds
R Lis, T K Morgan, R J DeVita, et al.
Journal of Medicinal Chemistry
|
March 14, 1997
Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site
T J Tucker, W C Lumma, A M Mulichak, et al.
Journal of Medicinal Chemistry
|
February 1, 1983
Conformational requirements for histamine H2-receptor inhibitors: a structure-activity study of phenylene analogues related to cimetidine and tiotidine
J M Hoffman, A M Pietruszkiewicz, C N Habecker, et al.
Journal of Medicinal Chemistry
|
August 1, 1987
Cardiotonic agents. 2. (Imidazolyl)aroylimidazolones, highly potent and selective positive inotropic agents
A A Hagedorn, P W Erhardt, W C Lumma, et al.
Journal of Medicinal Chemistry
|
April 17, 1998
Design of novel, potent, noncovalent inhibitors of thrombin with nonbasic P-1 substructures: rapid structure-activity studies by solid-phase synthesis
W C Lumma, K M Witherup, T J Tucker, et al.
Journal of Medicinal Chemistry
|
April 1, 1990
Synthesis and pharmacological studies of N-[4-[2-hydroxy-3-[[2-[4-(1H-imidazol-1- yl)phenoxy]ethyl]amino]propoxy]phenyl]methanesulfonamide, a novel antiarrhythmic agent with class II and class III activities
T K Morgan, R Lis, W C Lumma, et al.
Journal of Medicinal Chemistry
|
April 1, 1990
Synthesis and cardiac electrophysiological activity of N-substituted-4-(1H-imidazol-1-yl)benzamides--new selective class III agents
T K Morgan, R Lis, W C Lumma, et al.
Page
of 4